US20010028888A1 - Cosmetic or dermatological light protection agent preparations - Google Patents

Cosmetic or dermatological light protection agent preparations Download PDF

Info

Publication number
US20010028888A1
US20010028888A1 US09/771,593 US77159301A US2001028888A1 US 20010028888 A1 US20010028888 A1 US 20010028888A1 US 77159301 A US77159301 A US 77159301A US 2001028888 A1 US2001028888 A1 US 2001028888A1
Authority
US
United States
Prior art keywords
cosmetic
weight
methoxydibenzoylmethane
dermatological
tert
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
US09/771,593
Other versions
US6416773B2 (en
Inventor
Thomas Heidenfelder
Volker Schehlmann
Thomas Wunsch
Wilma Dausch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF SE
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10009442A external-priority patent/DE10009442A1/en
Priority claimed from DE2000144351 external-priority patent/DE10044351A1/en
Application filed by Individual filed Critical Individual
Assigned to BASF AKTIENGESELLSCHAFT reassignment BASF AKTIENGESELLSCHAFT ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: DAUSCH, WILMA M., HEIDENFELDER, THOMAS, WUENSCH, THOMAS, SCHEHLMANN, VOLKER
Publication of US20010028888A1 publication Critical patent/US20010028888A1/en
Application granted granted Critical
Publication of US6416773B2 publication Critical patent/US6416773B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A61Q1/04—Preparations containing skin colorants, e.g. pigments for lips
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations

Definitions

  • the invention relates to cosmetic or dermatological light protection agent preparations comprising a combination of one or more 3,3-diphenylacrylates and one or more dibenzoylmethane derivatives, and to the use thereof for the protection of human skin or human hair against UV rays.
  • the light protection agents used in cosmetic and dermatological preparations have the task of preventing or at least diminishing the extent of the harmful effects of sunlight on the human skin.
  • these light protection agents also serve to protect other ingredients from decomposition or degradation by UV radiation.
  • the aim is to prevent damage to the keratin fiber by UV rays.
  • UV-B radiation 280 to 320 nm
  • UV-A radiation >320 nm
  • the erythema activity maximum of sunlight is given as the relatively narrow region around 308 nm.
  • UV-A radiation leads to damage of the elastic and collagenic fibers of connective tissue, which leads to premature aging of the skin, and that it is to be regarded as a cause of numerous phototoxic and photoallergic reactions.
  • the harmful effect of UV-B radiation can be intensified by UV-A radiation.
  • French Patent Specification 2,440,933 describes 4-(1,1-dimethylethyl)-4′-methoxydibenzoylmethane as UV-A filter. It is proposed to combine this particular UV-A filter, which is sold by GIVAUDAN under the name “PARSOL 1789”, with different UV-B filters in order to absorb all the UV rays having a wavelength of from 280 to 380 nm.
  • this UV-A filter when used alone or in combination with UV-B filters, is insufficiently photochemically stable to ensure lasting protection of the skin during a prolonged session of sunbathing, which requires repeated applications at regular and brief intervals if effective protection of the skin against all UV rays is desired.
  • R 1 and R 2 are hydrogen, C 1 -C 12 -alkyl, C 1 -C 12 -alkoxy;
  • R 3 is C 3 -C 10 -cycloalkyl, optionally substituted
  • R 4 is hydrogen, CN and
  • R 5 to R 8 are hydrogen, C 1 -C 4 -alkyl
  • R 9 and R 10 are hydrogen, C 1 -C 12 -alkyl, C 1 -C 12 -alkoxy.
  • Alkyl radicals for R 1 and R 2 and also R 9 and R 10 which may be mentioned are branched or unbranched C 1 -C 12 -alkyl chains, preferably methyl, ethyl, n-propyl, 1-methylethyl, n-butyl, 1-methylpropyl, 2-methylpropyl, 1,1-dimethylethyl, n-pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 2,2-dimethylpropyl, 1-ethylpropyl, n-hexyl, 1,1-dimethylpropyl, 1,2-dimethylpropyl, 1-methylpentyl, 2-methylpentyl, 3-methylpentyl, 4-methylpentyl, 1,1-dimethylbutyl, 1,2-dimethylbutyl, 1,3-dimethylbutyl, 2,2-dimethylbutyl, 2,3-dimethylbutyl, 3,3-dimethyl
  • Alkyl radicals for R 5 to R 8 which may be mentioned are branched or unbranched C 1 -C 4 -alkyl chains, preferably methyl, ethyl, n-propyl, 1-methylethyl, n-butyl, 1-methylpropyl, 2-methylpropyl, 1,1-dimethylethyl.
  • Suitable alkoxy radicals for R 1 and R 2 and also R 9 and R 10 are straight-chain and branched radicals having 1 to 12 carbon atoms, preferably having 1 to 8 carbon atoms.
  • Cycloalkyl radicals for R 3 which may be mentioned are C 3 -C 10 -cycloalkyl radicals, such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl. Preference is given to C 5 -C 8 -cycloalkyl, such as cyclopentyl, cyclohexyl, cycloheptyl and cyclooctyl, in particular cyclopentyl and cyclohexyl.
  • the cycloalkyl radicals can be optionally substituted by up to three radicals, including halogen, e.g. fluorine, chlorine or bromine, cyano, nitro, amino, C 1 -C 4 -alkylamino, C 1 -C 4 -dialkylamino, hydroxyl, C 1 -C 4 -alkyl or C 1 -C 4 -alkoxy, or contain 1 to 3 heteroatoms, such as sulfur, nitrogen whose free valencies may be saturated by hydrogen or C 1 -C 4 -alkyl, or oxygen.
  • halogen e.g. fluorine, chlorine or bromine
  • cyano nitro
  • amino C 1 -C 4 -alkylamino
  • C 1 -C 4 -dialkylamino hydroxyl
  • C 1 -C 4 -alkyl or C 1 -C 4 -alkoxy or contain 1 to 3 heteroatoms, such as sulfur, nitrogen whose free valencies may be saturated
  • cycloalkyl radicals may also be present as bicyclic ring systems.
  • Preferred substituents on the cycloalkyl ring are C 1 -C 4 -alkyl groups, in particular methyl, ethyl, n-propyl, 1-methylethyl, n-butyl, 1-methylpropyl, 2-methylpropyl, 1,1-dimethylethyl.
  • R 3 Particularly preferred substituents for R 3 are the cycloalkyl radicals listed below.
  • R 3 is C 5 -C 8 -cycloalkyl, optionally substituted
  • R 3 is C 5 -C 8 -cycloalkyl, optionally substituted
  • the content of component a) in the cosmetic or dermatological light protection agent preparations according to the invention is in the range from 0.1 to 10% by weight, preferably from 0.1 to 6% by weight, particularly preferably in the range from 0.3 to 3% by weight, very particularly preferably in the range from 1.5 to 2.5% by weight.
  • the content of component b) in the cosmetic or dermatological light protection agent preparations according to the invention is in the range from 0.1 to 10% by weight, preferably from 0.2 to 7% by weight, particularly preferably in the range from 0.3 to 6% by weight, very particularly preferably in the range from 0.4 to 5% by weight.
  • the molar ratio of components a) and b) in the cosmetic or dermatological preparations is in a range a:b of from 0.5 to 10, preferably in a range from 1 to 8.
  • the cosmetic or dermatological preparations according to the invention exhibit a sunscreen factor of greater than 5, preferably greater than 10, particularly preferably greater than 20, very particularly preferably greater than 25.
  • the cosmetic and dermatological preparations comprising light protection agents are generally based on a carrier which comprises at least one oil phase. Accordingly, oils, oil-in-water and water-in-oil emulsions, creams and pastes, lip protection stick compositions or grease-free gels are suitable.
  • Cosmetic and dermatological preparations according to the invention furthermore advantageously comprise inorganic pigments based on metal oxides and/or other metal compounds which are insoluble or virtually insoluble in water, in particular the oxides of titanium (TiO 2 ), zinc (ZnO), iron (e.g. Fe 2 O 3 ), zirconium (ZrO 2 ), silicon (SiO 2 ), manganese (e.g. MnO), aluminum (Al 2 O 3 ), cerium (e.g. Ce 2 O 3 ), mixed oxides of the corresponding metals, and also mixtures of such oxides. Particular preference is given to pigments based on TiO 2 .
  • inorganic pigments based on metal oxides and/or other metal compounds which are insoluble or virtually insoluble in water, in particular the oxides of titanium (TiO 2 ), zinc (ZnO), iron (e.g. Fe 2 O 3 ), zirconium (ZrO 2 ), silicon (SiO 2 ), manganese (e.g. MnO
  • the inorganic pigments it is particularly advantageous, although not obligatory, for the inorganic pigments to be in hydrophobic form, i.e. for them to have been treated superficially to repel water.
  • This surface treatment can involve providing the pigments with a thin hydrophobic layer by methods known per se.
  • Such a process involves, for example, producing the hydrophobic surface layer by a reaction in accordance with
  • n and m are stoichiometric parameters to be used as desired, and R and R′ are the desired organic radicals.
  • hydrophobized pigments prepared analogously to DE-A 33 14 742 are advantageous.
  • Advantageous TiO 2 pigments are obtainable, for example, under the tradenames MT 100 T from TAYCA, and also M 160 from Kemira, and T 805 from Degussa.
  • the cosmetic or dermatological light protection preparations advantageously comprise inorganic pigments, in particular micropigments, in amounts of, for example, 0.1% by weight to 30% by weight, preferably in amounts from 0.5% by weight to 15% by weight, particularly preferably from 1% by weight to 10% by weight, very particularly preferably from 1.5 to 6% by weight, based on the total weight of the preparations.
  • the cosmetic and/or dermatological light protection formulations according to the invention can have the customary composition and be used for cosmetic and/or dermatological light protection, and also the treatment, care and cleansing of the skin and/or hair, and as make-up product in decorative cosmetics.
  • the cosmetic and dermatological preparations according to the invention are applied to the skin and/or the hair in a sufficient amount in the manner customary for cosmetics.
  • cosmetic and dermatological preparations which are in the form of a sunscreen.
  • These can advantageously additionally comprise at least one other UV-A filter and/or at least one further UV-B filter and/or at least one inorganic pigment, preferably an inorganic micropigment.
  • the cosmetic and dermatological preparations according to the invention can comprise cosmetic auxiliaries as are customarily used in such preparations, e.g. preservatives, bactericides, perfumes, antifoams, dyes, pigments which have a coloring action, thickeners, moisturizing and/or humectant substances, fats, oils, waxes or other customary constituents of a cosmetic or dermatological formulation, such as alcohols, polymers, foam stabilizers, electrolytes, organic solvents or silicone derivatives.
  • cosmetic auxiliaries as are customarily used in such preparations, e.g. preservatives, bactericides, perfumes, antifoams, dyes, pigments which have a coloring action, thickeners, moisturizing and/or humectant substances, fats, oils, waxes or other customary constituents of a cosmetic or dermatological formulation, such as alcohols, polymers, foam stabilizers, electrolytes, organic solvents or silicone derivatives.
  • antioxidants are generally preferred. According to the invention, favorable antioxidants are all antioxidants which are customary or suitable for cosmetic and/or dermatological applications.
  • the antioxidants are advantageously chosen from the group consisting of amino acids (e.g. glycine, histidine, tyrosine, tryptophan) and derivatives thereof, imidazoles (e.g. urocanic acid) and derivatives thereof, peptides, such as D,L-carnosine, D-carnosine, L-carnosine and derivatives thereof (e.g. anserine), carotinoids, carotenes (e.g. ⁇ -carotene, ⁇ -carotene, lycopene) and derivatives thereof, chlorogenic acid and derivatives thereof, liponic acid and derivatives thereof (e.g.
  • amino acids e.g. glycine, histidine, tyrosine, tryptophan
  • imidazoles e.g. urocanic acid
  • peptides such as D,L-carnosine, D-carnosine, L-carnosine and derivatives thereof (e.g. anserine)
  • thioredoxin glutathion, cysteine, cystine, cystamine and the glycosyl, N-acetyl, methyl, ethyl, propyl, amyl, butyl and lauryl, palmitoyl, oleyl-, ⁇ -linoleyl, cholesteryl and glyceryl esters thereof
  • salts thereof dilauryl thiodipropionate, distearyl thiodipropionate, thiodipropionic acid and derivatives thereof (esters, ethers, peptides, lipids, nucleotides, nucleosides and salts) and sulfoximine compounds (e.g.
  • buthionine sulfoximines in very small tolerated doses (e.g. pmol to ⁇ mol/kg), and also (metal) chelating agents (e.g. ⁇ -hydroxy fatty acids, palmitic acid, phytic acid, lactoferrin), ⁇ -hydroxy acids (e.g.
  • citric acid citric acid, lactic acid, malic acid
  • humic acid bile acid, bile extracts, bilirubin, biliverdin, EDTA, EGTA and derivatives thereof
  • unsaturated fatty acids and derivatives thereof e.g. ⁇ -linolenic acid, linoleic acid, oleic acid
  • folic acid and derivatives thereof furfurylidenesorbitol and derivatives thereof, ubiquinone and ubiquitol and derivatives thereof
  • vitamin C and derivatives e.g. ascorbyl palmitate, Mg ascorbyl phosphate, ascorbyl acetate
  • tocopherols and derivatives e.g.
  • vitamin E acetate
  • vitamin A and derivatives vitamin A palmitate
  • benzoin
  • the amount of the abovementioned antioxidants (one or more compounds) in the preparations is preferably 0.001 to 30% by weight, particularly preferably 0.05 to 20% by weight, in particular 1 to 10% by weight, based on the total weight of the preparation.
  • vitamin E and/or derivatives thereof are the antiodixant(s), it is advantageous to choose their respective concentrations from the range from 0.001 to 10% by weight, based on the total weight of the formulation. If vitamin A or vitamin A derivatives or carotenes or derivatives thereof are the antioxidant(s), it is advantageous to choose their respective concentrations from the range from 0.001 to 10% by weight, based on the total weight of the formulation.
  • the lipid phase can advantageously be chosen from the following groups of substance:
  • oils such as triglycerides of capric or of caprylic acid, but preferably castor oil;
  • fats, waxes and other natural and synthetic fatty substances preferably esters of fatty acids with alcohols of low carbon number, e.g. with isopropanol, propylene glycol or glycerol, or esters of fatty alcohols with alkanoic acids of low carbon number or with fatty acids; alkyl benzoates;
  • silicone oils such as dimethylpolysiloxanes, diethylpolysiloxanes, diphenylpolysiloxanes and mixed forms thereof.
  • the oil phase of the emulsions, oleogels or hydrodispersions or lipodispersions for the purposes of the present invention is advantageously chosen from the group of esters of saturated and/or unsaturated, branched and/or unbranched alkanecarboxylic acids of chain length from 3 to 30 carbon atoms, from the group of esters of aromatic carboxylic acids and saturated and/or unsaturated, branched and/or unbranched alcohols of chain length from 3 to 30 carbon atoms.
  • ester oils can then advantageously be chosen from the group consisting of isopropyl myristate, isopropyl palmitate, isopropyl stearate, isopropyl oleate, n-butyl stearate, n-hexyl laurate, n-decyl oleate, isooctyl stearate, isononyl stearate, isononyl isononanoate, 2-ethylhexyl palmitate, 2-ethylhexyl laurate, 2-hexyldecyl stearate, 2-octyldodecyl palmitate, oleyl oleate, oleyl erucate, erucyl oleate, erucyl erucate, and synthetic, semisynthetic and natural mixtures of such esters, e.g. jojoba oil.
  • the oil phase can furthermore advantageously be chosen from the group of branched and unbranched hydrocarbons and hydrocarbon waxes, silicone oils, dialkyl ethers, the group of saturated or unsaturated, branched or unbranched alcohols, and the fatty acid triglycerides, namely the triglycerol esters of saturated and/or unsaturated, branched and/or unbranched alkanecarboxylic acids of chain length from 8 to 24, in particular 12 to 18, carbon atoms.
  • the fatty acid triglycerides can, for example, be advantageously chosen from the group of synthetic, semisynthetic and natural oils, e.g. olive oil, sunflower oil, soybean oil, groundnut oil, rapeseed oil, almond oil, palm oil, coconut oil, palm kernel oil and the like.
  • any mixtures of such oil and wax components can be advantageously used for the purposes of the present invention. It may also be advantageous in some instances to use waxes, for example cetyl palmitate, as the sole lipid component of the oil phase.
  • the oil phase is advantageously chosen from the group consisting of 2-ethylhexyl isostearate, octyldodecanol, isotridecyl isononanoate, isoeicosane, 2-ethylhexyl cocoate, C 12 - 15 -alkylbenzoate, caprylic/capric triglyceride, dicaprylic ether.
  • Particularly advantageous mixtures comprise C 12 - 15 -alkyl benzoate, 2-ethylhexyl isostearate and isotridecyl isononanoate.
  • paraffin oil squalane and squalene are advantageous for the purposes of the present invention.
  • the oil phase can further advantageously have a content of cyclic or linear silicone oils or consist entirely of such oils, although it is preferred, apart from the silicone oil or silicone oils, to use an additional content of other oil phase components.
  • Cyclomethicone (octamethylcyclotetrasiloxane) is advantageously used as the silicone oil to be used according to the invention.
  • other silicone oils are also advantageous for the purposes of the present invention, for example, hexamethylcyclotrisiloxane, polydimethylsiloxane, poly(methylphenylsiloxane).
  • mixtures comprise cyclomethicone and isotridecyl isononanoate, or cyclomethicone and 2-ethylhexyl isostearate.
  • the aqueous phase of the preparations according to the invention optionally advantageously comprises
  • alcohols, diols or polyols of low carbon number, and ethers thereof preferably ethanol, isopropanol, propylene glycol, glycerol, ethylene glycol, ethylene glycol monoethyl or monobutyl ether, propylene glycol monomethyl, monoethyl or monobutyl ether, diethylene glycol monomethyl or monoethyl ether and analogous products, and in particular one or more thickeners, which can advantageously be chosen from the group consisting of silicon dioxide, aluminum silicates, polysaccharides or derivatives thereof, e.g.
  • hyaluronic acid, xanthan gum, hydroxypropylmethylcellulose particularly advantageously from the group of polyacrylates, preferably a polyacrylate from the group of so-called Carbopols, for example Carbopols types 980, 981, 1382, 2984, 5984, each individually or in combination.
  • Carbopols for example Carbopols types 980, 981, 1382, 2984, 5984, each individually or in combination.
  • UV filters The list of UV filters given which can be used in combination with the active ingredient combinations according to the invention is not, of course, intended to be limiting.
  • the light protection preparations according to the invention can be used as shampoos, lotions, gels, hair sprays, aerosol foam creams or emulsions, inter alia, for washing, coloring and for styling the hair.
  • UV filter action of the preparations according to the invention can also be utilized for stabilizing active ingredient and auxiliaries in cosmetic and dermatological formulations.
  • the combination according to the invention is particularly notable for the fact that it leads to significant photostabilization of dibenzoylmethane derivatives (see Example 14).
  • composition for sun blocker containing micropigments Mass content (% by weight) ad 100 water 10.00 octyl methoxycinnamate 6.00 PEG-7 hydrogenated castor oil 6.00 titanium dioxide, micronized 3.00 cyclohexyl 2-cyano-3,3-diphenylacrylate (prepared as in Example 2) 1.50 4-tert-butyl-4′-methoxydibenzoylmethane 5.00 mineral oil 5.00 isoamyl p-methoxycinnamate 5.00 propylene glycol 3.00 jojoba oil 3.00 4-methylbenzylidenecamphor 2.00 PEG-45/dodecyl glycol copolymer 1.00 dimethicone 0.50 PEG-40 hydrogenated castor oil 0.50 tocopheryl acetate 0.50 phenoxyethanol 0.20 EDTA
  • Non-greasy gel Mass content (% by weight) ad 100 water 8.00 octyl methoxycinnamate 7.00 titanium dioxide, micronized 3.00 cyclohexyl 2-cyano-3,3-diphenylacrylate (prepared as in Example 2) 1.50 4-tert-butyl-4′-methoxydibenzoylmethane 5.00 glycerol 5.00 PEG-25 PABA 1.00 4-methylbenzylidenecamphor 0.40 acrylates C10-C30 alkyl acrylate crosspolymer 0.30 imidazolidinylurea 0.25 hydroxyethylcellulose 0.25 sodium methylparaben 0.20 disodium EDTA 0.15 fragrance 0.15 sodium propylparaben 0.10 sodium hydroxide
  • Sunmilk (SPF 6) Mass content (% by weight) ad 100 water 10.00 mineral oil 6.00 PEG-7 hydrogenated castor oil 5.00 isopropyl palmitate 3.50 octyl methoxycinnamate 3.00 cyclohexyl 2-cyano-3,3-diphenylacrylate (prepared as in Example 2) 1.50 4-tert-butyl-4′-methoxydibenzoylmethane 3.00 caprylic/capric triglyceride 3.00 jojoba oil 2.00 PEG-45/dodecyl glycol copolymer 0.70 magnesium sulfate 0.60 magnesium stearate 0.50 tocopheryl acetate 3.00 glycerol 0.25 methylparaben 0.15 propylparaben 0.05 tocopherol
  • Liquid make-up Mass content (% by weight) ad 100 water 2.00 cetearyl alcohol 2.00 ceteareth 25 6.00 glycerol monostearate 1.00 cetyl alcohol 8.00 paraffin oil 7.00 cetearyl octanoate 0.2 dimethicone 3.00 propylene glycol 1.00 panthenol 3.00 cyclohexyl 2-cyano-3,3-diphenylacrylate (prepared as in Example 2) 1.50 4-tert-butyl-4′-methoxydibenzoylmethane 3.50 octyl methoxycinnamate 0.1 bisabolol 5.70 titanium dioxide 1.10 iron oxide q.s. fragrance
  • a 2% strength by weight alcoholic solution of the light protection agent to be tested was applied, using an Eppendorf pipette (20 ⁇ l), to the milled area of a small glass plate. Owing to the presence of the alcohol, the solution distributed uniformly on the roughened surface of the glass. (The amount applied corresponds to the amount of light protection agent required to achieve an average sun protection factor in suncreams.)
  • 4 small glass plates were irradiated in each case. The irradiation time was 30/60/90/120 minutes in each case. The small glass plates were cooled slightly during irradiation by water cooling located at the base of the suntest apparatus. The temperature inside the sun test apparatus was 40° C. during irradiation.
  • the samples After the samples had been irradiated, they were washed with ethanol in a dark 50 ml graduated flask, and measured using a photometer. The blank samples were likewise applied to small glass plates and evaporated for 30 minutes at room temperature. Like the other samples, they were washed off with ethanol, diluted to 100 ml and measured.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention relates to cosmetic or dermatological preparations comprising
a) 0.1 to 10% by weight of one or more 3,3-diphenylacrylates of the formula I,
Figure US20010028888A1-20011011-C00001
and
b) 0.1 to 10% by weight of one or more dibenzoylmethane derivatives of the formula II,
Figure US20010028888A1-20011011-C00002
in which the substituents R1 to R10 independently of one another have the meanings given in the description.

Description

  • The invention relates to cosmetic or dermatological light protection agent preparations comprising a combination of one or more 3,3-diphenylacrylates and one or more dibenzoylmethane derivatives, and to the use thereof for the protection of human skin or human hair against UV rays. [0001]
  • The light protection agents used in cosmetic and dermatological preparations have the task of preventing or at least diminishing the extent of the harmful effects of sunlight on the human skin. In addition, these light protection agents, however, also serve to protect other ingredients from decomposition or degradation by UV radiation. In hair cosmetic formulations, the aim is to prevent damage to the keratin fiber by UV rays. [0002]
  • The sunlight which reaches the earth's surface contains UV-B radiation (280 to 320 nm) and UV-A radiation (>320 nm), which directly border the visible light region. The effect on human skin is evident, particularly in the case of UV-B radiation, from sunburn. [0003]
  • The erythema activity maximum of sunlight is given as the relatively narrow region around 308 nm. [0004]
  • Numerous compounds are known for protecting against UV-B radiation; these are, inter alia, derivatives of 3-benzylidenecamphor, of 4-aminobenzoic acid, of cinnamic acid, of salicylic acid, of benzophenone, and of 2-phenylbenzimidazole. [0005]
  • For the region between about 320 nm and about 400 nm, the UV-A region, it is also important to have available filter substances, since the rays of that region can also trigger reactions in cases of skin which is sensitive to light. It has been found that UV-A radiation leads to damage of the elastic and collagenic fibers of connective tissue, which leads to premature aging of the skin, and that it is to be regarded as a cause of numerous phototoxic and photoallergic reactions. The harmful effect of UV-B radiation can be intensified by UV-A radiation. [0006]
  • To protect against UV-A rays, derivatives of dibenzoylmethane are used, although their photostability is inadequate (Int. J. Cosm. Science 10, 53 (1988)). [0007]
  • French Patent Specification 2,440,933 describes 4-(1,1-dimethylethyl)-4′-methoxydibenzoylmethane as UV-A filter. It is proposed to combine this particular UV-A filter, which is sold by GIVAUDAN under the name “PARSOL 1789”, with different UV-B filters in order to absorb all the UV rays having a wavelength of from 280 to 380 nm. [0008]
  • However, this UV-A filter, when used alone or in combination with UV-B filters, is insufficiently photochemically stable to ensure lasting protection of the skin during a prolonged session of sunbathing, which requires repeated applications at regular and brief intervals if effective protection of the skin against all UV rays is desired. [0009]
  • For this reason, according to U.S. Pat. No. 5,587,150 and U.S. Pat. No. 5,576,354, the insufficiently photostable UV-A filters are stabilized by the addition of 2-cyano-3,3-diphenylacrylates, which themselves serve as filters in the UV-B region. [0010]
  • The combinations of dibenzoylmethane and 2-cyano-3,3-diphenylacrylate mentioned in U.S. Pat. No. 5,587,150 and U.S. Pat. No. 5,576,354 have the disadvantage that the preparations prepared therewith in many cases still have inadequate cosmetic properties, such as, for example, tackiness which is too high and, associated therewith, an unsatisfactory feel on the skin. [0011]
  • It is an object of the invention to provide novel stabilizers for UV-A filters from the class of dibenzoylmethanes which do not have the abovementioned disadvantages. [0012]
  • It is furthermore an object of the present invention to propose light protection agents for cosmetic and dermatological purposes which absorb in the UV-A region with high absorbance, which are photostable, have low intrinsic color, i.e. a sharp band structure, and are readily processable in oil or water. [0013]
  • We have found that this object is achieved by cosmetic or dermatological preparations comprising [0014]
  • a) 0.1 to 10% by weight of one or more 3,3-diphenylacrylates of the formula I, [0015]
    Figure US20010028888A1-20011011-C00003
  • in which the substituents independently of one another have the following meanings: [0016]
  • R[0017] 1 and R2 are hydrogen, C1-C12-alkyl, C1-C12-alkoxy;
  • R[0018] 3 is C3-C10-cycloalkyl, optionally substituted;
  • R[0019] 4 is hydrogen, CN and
  • b) 0.1 to 10% by weight of one or more dibenzoylmethane derivatives of the formula II, [0020]
    Figure US20010028888A1-20011011-C00004
  • in which the substituents independently of one another have the following meanings: [0021]  
  • R[0022] 5 to R8 are hydrogen, C1-C4-alkyl;
  • R[0023] 9 and R10 are hydrogen, C1-C12-alkyl, C1-C12-alkoxy.
  • Alkyl radicals for R[0024] 1 and R2 and also R9 and R10 which may be mentioned are branched or unbranched C1-C12-alkyl chains, preferably methyl, ethyl, n-propyl, 1-methylethyl, n-butyl, 1-methylpropyl, 2-methylpropyl, 1,1-dimethylethyl, n-pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 2,2-dimethylpropyl, 1-ethylpropyl, n-hexyl, 1,1-dimethylpropyl, 1,2-dimethylpropyl, 1-methylpentyl, 2-methylpentyl, 3-methylpentyl, 4-methylpentyl, 1,1-dimethylbutyl, 1,2-dimethylbutyl, 1,3-dimethylbutyl, 2,2-dimethylbutyl, 2,3-dimethylbutyl, 3,3-dimethylbutyl, 1-ethylbutyl, 2-ethylbutyl, 1,1,2-trimethylpropyl, 1,2,2-trimethylpropyl, 1-ethyl-1-methylpropyl, 1-ethyl-2-methylpropyl, n-heptyl, n-octyl, 2-ethylhexyl, 1,1,3-trimethylhexyl, 1,1,3,3-tetramethylpentyl, n-nonyl, n-decyl, n-undecyl, 1-methylundecyl, n-dodecyl.
  • Alkyl radicals for R[0025] 5 to R8 which may be mentioned are branched or unbranched C1-C4-alkyl chains, preferably methyl, ethyl, n-propyl, 1-methylethyl, n-butyl, 1-methylpropyl, 2-methylpropyl, 1,1-dimethylethyl.
  • Suitable alkoxy radicals for R[0026] 1 and R2 and also R9 and R10 are straight-chain and branched radicals having 1 to 12 carbon atoms, preferably having 1 to 8 carbon atoms.
  • Examples which may be mentioned are: [0027]
  • methoxy ethoxy [0028]
  • isopropoxy n-propoxy [0029]
  • 1-methylpropoxy n-butoxy [0030]
  • n-pentoxy 2-methylpropoxy [0031]
  • 3-methylbutoxy 1,1-dimethylpropoxy [0032]
  • 2,2-dimethylpropoxy hexoxy [0033]
  • 1-methyl-1-ethylpropoxy heptoxy [0034]
  • octoxy 2-ethylhexoxy [0035]
  • Cycloalkyl radicals for R[0036] 3 which may be mentioned are C3-C10-cycloalkyl radicals, such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl. Preference is given to C5-C8-cycloalkyl, such as cyclopentyl, cyclohexyl, cycloheptyl and cyclooctyl, in particular cyclopentyl and cyclohexyl.
  • The cycloalkyl radicals can be optionally substituted by up to three radicals, including halogen, e.g. fluorine, chlorine or bromine, cyano, nitro, amino, C[0037] 1-C4-alkylamino, C1-C4-dialkylamino, hydroxyl, C1-C4-alkyl or C1-C4-alkoxy, or contain 1 to 3 heteroatoms, such as sulfur, nitrogen whose free valencies may be saturated by hydrogen or C1-C4-alkyl, or oxygen.
  • The cycloalkyl radicals may also be present as bicyclic ring systems. [0038]
  • Preferred substituents on the cycloalkyl ring are C[0039] 1-C4-alkyl groups, in particular methyl, ethyl, n-propyl, 1-methylethyl, n-butyl, 1-methylpropyl, 2-methylpropyl, 1,1-dimethylethyl.
  • Particularly preferred substituents for R[0040] 3 are the cycloalkyl radicals listed below.
    Figure US20010028888A1-20011011-C00005
  • Preference is given to cosmetic or dermatological preparations comprising [0041]
  • a) 0.1 to 10% by weight of one or more 3,3-diphenylacrylates of the formula Ib, [0042]
    Figure US20010028888A1-20011011-C00006
  • in which R[0043]   3 is C5-C8-cycloalkyl, optionally substituted and
  • b) 0.1 to 10% by weight of one or more dibenzoylmethane derivatives, chosen from the group consisting of [0044]
  • 2-methyldibenzoylmethane, 4-methyldibenzoylmethane, [0045]
  • 4-isopropyldibenzoylmethane, 4-tert-butyldibenzoylmethane, [0046]
  • 2,4-dimethyldibenzoylmethane, 2,5-dimethyldibenzoylmethane, [0047]
  • 4,4′-diisopropyldibenzoylmethane, [0048]
  • 4-tert-butyl-4′-methoxydibenzoylmethane, [0049]
  • 2-methyl-5-isopropyl-4′-methoxydibenzoylmethane, [0050]
  • 2-methyl-5-tert-butyl-4′-methoxydibenzoylmethane, [0051]
  • 2,4-dimethyl-4′-methoxydibenzoylmethane, [0052]
  • 2,6-dimethyl-4-tert-butyl-4′-methoxydibenzoylmethane. [0053]
  • Particular preference is given to cosmetic or dermatological preparations comprising [0054]
  • a) 0.1 to 10% by weight of one or more 3,3-diphenylacrylates of the formula Ib, [0055]
    Figure US20010028888A1-20011011-C00007
  • in which R[0056]   3 is C5-C8-cycloalkyl, optionally substituted and
  • b) 0.1 to 10% by weight of 4-tert-butyl-4′-methoxydibenzoylmethane. [0057]
  • The content of component a) in the cosmetic or dermatological light protection agent preparations according to the invention is in the range from 0.1 to 10% by weight, preferably from 0.1 to 6% by weight, particularly preferably in the range from 0.3 to 3% by weight, very particularly preferably in the range from 1.5 to 2.5% by weight. [0058]
  • The content of component b) in the cosmetic or dermatological light protection agent preparations according to the invention is in the range from 0.1 to 10% by weight, preferably from 0.2 to 7% by weight, particularly preferably in the range from 0.3 to 6% by weight, very particularly preferably in the range from 0.4 to 5% by weight. [0059]
  • The molar ratio of components a) and b) in the cosmetic or dermatological preparations is in a range a:b of from 0.5 to 10, preferably in a range from 1 to 8. [0060]
  • The cosmetic or dermatological preparations according to the invention exhibit a sunscreen factor of greater than 5, preferably greater than 10, particularly preferably greater than 20, very particularly preferably greater than 25. [0061]
  • The cosmetic and dermatological preparations comprising light protection agents are generally based on a carrier which comprises at least one oil phase. Accordingly, oils, oil-in-water and water-in-oil emulsions, creams and pastes, lip protection stick compositions or grease-free gels are suitable. [0062]
  • Cosmetic and dermatological preparations according to the invention furthermore advantageously comprise inorganic pigments based on metal oxides and/or other metal compounds which are insoluble or virtually insoluble in water, in particular the oxides of titanium (TiO[0063] 2), zinc (ZnO), iron (e.g. Fe2O3), zirconium (ZrO2), silicon (SiO2), manganese (e.g. MnO), aluminum (Al2O3), cerium (e.g. Ce2O3), mixed oxides of the corresponding metals, and also mixtures of such oxides. Particular preference is given to pigments based on TiO2.
  • For the purposes of the present invention, it is particularly advantageous, although not obligatory, for the inorganic pigments to be in hydrophobic form, i.e. for them to have been treated superficially to repel water. This surface treatment can involve providing the pigments with a thin hydrophobic layer by methods known per se. [0064]
  • Such a process involves, for example, producing the hydrophobic surface layer by a reaction in accordance with [0065]
  • nTiO2+m(RO)3Si—R′→nTiO2   (surf.)
  • here, n and m are stoichiometric parameters to be used as desired, and R and R′ are the desired organic radicals. For example, hydrophobized pigments prepared analogously to DE-A 33 14 742 are advantageous. [0066]
  • Advantageous TiO[0067] 2 pigments are obtainable, for example, under the tradenames MT 100 T from TAYCA, and also M 160 from Kemira, and T 805 from Degussa.
  • The cosmetic or dermatological light protection preparations advantageously comprise inorganic pigments, in particular micropigments, in amounts of, for example, 0.1% by weight to 30% by weight, preferably in amounts from 0.5% by weight to 15% by weight, particularly preferably from 1% by weight to 10% by weight, very particularly preferably from 1.5 to 6% by weight, based on the total weight of the preparations. [0068]
  • The cosmetic and/or dermatological light protection formulations according to the invention can have the customary composition and be used for cosmetic and/or dermatological light protection, and also the treatment, care and cleansing of the skin and/or hair, and as make-up product in decorative cosmetics. [0069]
  • For use, the cosmetic and dermatological preparations according to the invention are applied to the skin and/or the hair in a sufficient amount in the manner customary for cosmetics. [0070]
  • Particular preference is given to cosmetic and dermatological preparations which are in the form of a sunscreen. These can advantageously additionally comprise at least one other UV-A filter and/or at least one further UV-B filter and/or at least one inorganic pigment, preferably an inorganic micropigment. [0071]
  • The cosmetic and dermatological preparations according to the invention can comprise cosmetic auxiliaries as are customarily used in such preparations, e.g. preservatives, bactericides, perfumes, antifoams, dyes, pigments which have a coloring action, thickeners, moisturizing and/or humectant substances, fats, oils, waxes or other customary constituents of a cosmetic or dermatological formulation, such as alcohols, polymers, foam stabilizers, electrolytes, organic solvents or silicone derivatives. [0072]
  • An additional content of antioxidants is generally preferred. According to the invention, favorable antioxidants are all antioxidants which are customary or suitable for cosmetic and/or dermatological applications. [0073]
  • The antioxidants are advantageously chosen from the group consisting of amino acids (e.g. glycine, histidine, tyrosine, tryptophan) and derivatives thereof, imidazoles (e.g. urocanic acid) and derivatives thereof, peptides, such as D,L-carnosine, D-carnosine, L-carnosine and derivatives thereof (e.g. anserine), carotinoids, carotenes (e.g. α-carotene, β-carotene, lycopene) and derivatives thereof, chlorogenic acid and derivatives thereof, liponic acid and derivatives thereof (e.g. dihydroliponic acid), aurothioglucose, propylthiouracil and other thioles (e.g. thioredoxin, glutathion, cysteine, cystine, cystamine and the glycosyl, N-acetyl, methyl, ethyl, propyl, amyl, butyl and lauryl, palmitoyl, oleyl-, γ-linoleyl, cholesteryl and glyceryl esters thereof) and salts thereof, dilauryl thiodipropionate, distearyl thiodipropionate, thiodipropionic acid and derivatives thereof (esters, ethers, peptides, lipids, nucleotides, nucleosides and salts) and sulfoximine compounds (e.g. buthionine sulfoximines, homocystein sulfoximine, buthionine sulfones, penta-, hexa-, heptathionine sulfoximine) in very small tolerated doses (e.g. pmol to μmol/kg), and also (metal) chelating agents (e.g. α-hydroxy fatty acids, palmitic acid, phytic acid, lactoferrin), α-hydroxy acids (e.g. citric acid, lactic acid, malic acid), humic acid, bile acid, bile extracts, bilirubin, biliverdin, EDTA, EGTA and derivatives thereof, unsaturated fatty acids and derivatives thereof (e.g. γ-linolenic acid, linoleic acid, oleic acid), folic acid and derivatives thereof, furfurylidenesorbitol and derivatives thereof, ubiquinone and ubiquitol and derivatives thereof, vitamin C and derivatives (e.g. ascorbyl palmitate, Mg ascorbyl phosphate, ascorbyl acetate), tocopherols and derivatives (e.g. vitamin E acetate), vitamin A and derivatives (vitamin A palmitate) and koniferyl benzoate of benzoin, rutinic acid and derivatives thereof, α-glycosylrutin, ferulic acid, furfurylideneglucitol, carnosene, butylhydroxytoluene, butylhydroxyanisol, nordihydroguaiac acid, nordihydroguaiaretic acid, trihydroxybutyrophenone, uric acid and derivatives thereof, mannose and derivatives thereof, zinc and derivatives thereof (e.g. ZnO, ZnSO[0074] 4), selenium and derivatives thereof (e.g. selenomethionine), stilbenes and derivatives thereof (e.g. stilbene oxide, trans-stilbene oxide) and the derivatives (salts, esters, ethers, sugars, nucleotides, nucleosides, peptides and lipids) of said active ingredients which are suitable according to the invention.
  • The amount of the abovementioned antioxidants (one or more compounds) in the preparations is preferably 0.001 to 30% by weight, particularly preferably 0.05 to 20% by weight, in particular 1 to 10% by weight, based on the total weight of the preparation. [0075]
  • If vitamin E and/or derivatives thereof are the antiodixant(s), it is advantageous to choose their respective concentrations from the range from 0.001 to 10% by weight, based on the total weight of the formulation. If vitamin A or vitamin A derivatives or carotenes or derivatives thereof are the antioxidant(s), it is advantageous to choose their respective concentrations from the range from 0.001 to 10% by weight, based on the total weight of the formulation. [0076]
  • The lipid phase can advantageously be chosen from the following groups of substance: [0077]
  • mineral oils, mineral waxes [0078]
  • oils, such as triglycerides of capric or of caprylic acid, but preferably castor oil; [0079]
  • fats, waxes and other natural and synthetic fatty substances, preferably esters of fatty acids with alcohols of low carbon number, e.g. with isopropanol, propylene glycol or glycerol, or esters of fatty alcohols with alkanoic acids of low carbon number or with fatty acids; alkyl benzoates; [0080]
  • silicone oils, such as dimethylpolysiloxanes, diethylpolysiloxanes, diphenylpolysiloxanes and mixed forms thereof. [0081]
  • The oil phase of the emulsions, oleogels or hydrodispersions or lipodispersions for the purposes of the present invention is advantageously chosen from the group of esters of saturated and/or unsaturated, branched and/or unbranched alkanecarboxylic acids of chain length from 3 to 30 carbon atoms, from the group of esters of aromatic carboxylic acids and saturated and/or unsaturated, branched and/or unbranched alcohols of chain length from 3 to 30 carbon atoms. Such ester oils can then advantageously be chosen from the group consisting of isopropyl myristate, isopropyl palmitate, isopropyl stearate, isopropyl oleate, n-butyl stearate, n-hexyl laurate, n-decyl oleate, isooctyl stearate, isononyl stearate, isononyl isononanoate, 2-ethylhexyl palmitate, 2-ethylhexyl laurate, 2-hexyldecyl stearate, 2-octyldodecyl palmitate, oleyl oleate, oleyl erucate, erucyl oleate, erucyl erucate, and synthetic, semisynthetic and natural mixtures of such esters, e.g. jojoba oil. [0082]
  • The oil phase can furthermore advantageously be chosen from the group of branched and unbranched hydrocarbons and hydrocarbon waxes, silicone oils, dialkyl ethers, the group of saturated or unsaturated, branched or unbranched alcohols, and the fatty acid triglycerides, namely the triglycerol esters of saturated and/or unsaturated, branched and/or unbranched alkanecarboxylic acids of chain length from 8 to 24, in particular 12 to 18, carbon atoms. The fatty acid triglycerides can, for example, be advantageously chosen from the group of synthetic, semisynthetic and natural oils, e.g. olive oil, sunflower oil, soybean oil, groundnut oil, rapeseed oil, almond oil, palm oil, coconut oil, palm kernel oil and the like. [0083]
  • Also, any mixtures of such oil and wax components can be advantageously used for the purposes of the present invention. It may also be advantageous in some instances to use waxes, for example cetyl palmitate, as the sole lipid component of the oil phase. [0084]
  • The oil phase is advantageously chosen from the group consisting of 2-ethylhexyl isostearate, octyldodecanol, isotridecyl isononanoate, isoeicosane, 2-ethylhexyl cocoate, C[0085] 12-15-alkylbenzoate, caprylic/capric triglyceride, dicaprylic ether.
  • Particularly advantageous mixtures comprise C[0086] 12-15-alkyl benzoate, 2-ethylhexyl isostearate and isotridecyl isononanoate.
  • Of the hydrocarbons, paraffin oil, squalane and squalene are advantageous for the purposes of the present invention. [0087]
  • The oil phase can further advantageously have a content of cyclic or linear silicone oils or consist entirely of such oils, although it is preferred, apart from the silicone oil or silicone oils, to use an additional content of other oil phase components. [0088]
  • Cyclomethicone (octamethylcyclotetrasiloxane) is advantageously used as the silicone oil to be used according to the invention. However, other silicone oils are also advantageous for the purposes of the present invention, for example, hexamethylcyclotrisiloxane, polydimethylsiloxane, poly(methylphenylsiloxane). [0089]
  • Other particularly advantageous mixtures comprise cyclomethicone and isotridecyl isononanoate, or cyclomethicone and 2-ethylhexyl isostearate. [0090]
  • The aqueous phase of the preparations according to the invention optionally advantageously comprises [0091]
  • alcohols, diols or polyols of low carbon number, and ethers thereof, preferably ethanol, isopropanol, propylene glycol, glycerol, ethylene glycol, ethylene glycol monoethyl or monobutyl ether, propylene glycol monomethyl, monoethyl or monobutyl ether, diethylene glycol monomethyl or monoethyl ether and analogous products, and in particular one or more thickeners, which can advantageously be chosen from the group consisting of silicon dioxide, aluminum silicates, polysaccharides or derivatives thereof, e.g. hyaluronic acid, xanthan gum, hydroxypropylmethylcellulose, particularly advantageously from the group of polyacrylates, preferably a polyacrylate from the group of so-called Carbopols, for example Carbopols types 980, 981, 1382, 2984, 5984, each individually or in combination. [0092]
  • It is further advantageous, apart from the combinations according to the invention, to use additional oil-soluble organic UV-A filters and/or UV-B filters in the lipid phase and/or water-soluble organic UV-A filters and/or UV-B filters in the aqueous phase, the total amount of filter substances being, for example, 0.1% by weight to 30% by weight, preferably 0.5 to 15% by weight, in particular 1 to 10% by weight, based on the total weight of the preparations, in order to make available cosmetic preparations which protect the skin from the entire region of ultraviolet radiation. [0093]
  • Examples which may be mentioned are: [0094]
  • Table 1: [0095]
    CAS No.
    No. Substance (=acid)
    1 4-aminobenzoic acid 150-13-0
    2 3-(4′-trimethylammonio)benzylidenebornan-2-one 52793-97-2
    methylsulfate
    3 3,3,5-trimethylcyclohexyl salicylate 118-56-9
    (homosalate)
    4 2-hydroxy-4-methoxybenzophenone (oxybenzone) 131-57-7
    5 2-phenylbenzimidazole-5-sulfonic acid and its 27503-81-7
    potassium, sodium and triethanolamine salts
    6 3,3′-(1,4-phenylenedimethine)bis(7,7-dimethyl- 90457-82-2
    2-oxobicyclo[2.2.1]heptane-1-methanesulfonic
    acid) and its salts
    7 polyethoxyethyl 4-bis(polyethoxy)aminobenzoate 113010-52-9
    8 2-ethylhexyl 4-dimethylaminobenzoate 21245-02-3
    9 2-ethylhexyl salicylate 118-60-5
    10 isoamyl 4-methoxycinnamate 71617-10-2
    11 2-ethylhexyl 4-methoxycinnamate 5466-77-3
    12 2-hydroxy-4-methoxybenzophenone-5-sulfonic acid 4065-45-6
    (sulisobenzone) and the sodium salt
    13 3-(4′-sulfobenzylidene)bornane-2-one and salts 58030-58-6
    14 3-benzylidenebornane-2-one 16087-24-8
    15 1-(4′-isopropylphenyl)-3-phenylpropane- 63260-25-9
    1,3-dione
    16 4-isopropylbenzyl salicylate 94134-93-7
    17 2,4,6-trianilino(o-carbo-2′-ethylhexyl-1′-oxy)- 88122-99-0
    1,3,5-triazine
    18 3-imidazol-4-ylacrylic acid and its ethyl ester 104-98-3
    19 menthyl o-aminobenzoate or: 134-09-8
    5-methyl-2-(1-methylethyl)-2-aminobenzoates
    20 glyceryl p-aminobenzoate or: 136-44-7
    1-glyceryl 4-aminobenzoate
    21 2,2′-dihydroxy-4-methoxybenzophenone (dioxyben- 131-53-3
    zone)
    22 2-hydroxy-4-methoxy-4-methylbenzophenone 1641-17-4
    (mexenone)
    23 triethanolamine salicylate 2174-16-5
    24 dimethoxyphenylglyoxalic acid or: sodium 4732-70-1
    3,4-dimethoxyphenylglyoxalate
    25 3-(4′-sulfobenzylidene)bornan-2-one and its 56039-58-8
    salts
    26 2,2′,4,4′-tetrahydroxybenzophenone 131-55-5
    27 2,2′-methylenebis[6-(2H-benzotria- 103597-45-1
    zol-2-yl)-4-(1,1,3,3,-tetramethylbutyl)phenol]
    28 2,2′-(1,4-phenylene)bis-1H-benzimida- 180898-37-7
    zole-4,6-disulfonic acid, Na salt
    29 2,4-bis[4-(2-ethylhexyloxy)-2-hydroxy]phe- 187393-00-6
    nyl-6-(4-methoxyphenyl)-(1,3,5)triazine
    30 3-(4-methylbenzylidene)camphor 36861-47-9
    31 polyethoxyethyl 4-bis(polyethoxy)paraamino- 113010-52-9
    benzoate
    32 2,4-dihydroxybenzophenone 131-56-6
    33 2,2′-dihydroxy-4,4′-dimethoxybenzophenone- 3121-60-6
    5,5′-disodium sulfonate
  • Other light protection agents which can be combined are, inter alia, the following compounds: [0096]
    Figure US20010028888A1-20011011-C00008
  • The list of UV filters given which can be used in combination with the active ingredient combinations according to the invention is not, of course, intended to be limiting. [0097]
  • To protect human hair against UV rays, the light protection preparations according to the invention can be used as shampoos, lotions, gels, hair sprays, aerosol foam creams or emulsions, inter alia, for washing, coloring and for styling the hair. [0098]
  • The UV filter action of the preparations according to the invention can also be utilized for stabilizing active ingredient and auxiliaries in cosmetic and dermatological formulations. [0099]
  • The combination according to the invention is particularly notable for the fact that it leads to significant photostabilization of dibenzoylmethane derivatives (see Example 14). [0100]
  • The examples below serve to illustrate the present invention without limiting it. [0101]
    • I. PREPARATION     EXAMPLE 1 Cyclopentyl 2-cyano-3,3-diphenylacrylate
  • 83.1 g (0.3 mol) of ethyl 2-cyano-3,3-diphenylacrylate (Uvinul 3035), 100 ml of cyclopentanol and 6 g of Na[0102] 2CO3 were reacted with one another at 145° C. with distillative removal of the ethanol formed, assisted by a stream of nitrogen. After about 3 h, the reaction mixture was filtered hot in order to remove the Na2CO3. After the filtrate had been cooled, the precipitate which had formed was filtered off, washed with petroleum ether and dried, giving 78.1 g (82%) of cyclopentyl 2-cyano-3,3-diphenylacrylate as a colorless solid. [λmax 300 nm; E1 1 (MeOH) 395]
    • EXAMPLE 2 Cyclohexyl 2-cyano-3,3-diphenylacrylate
  • 139 g (0.5 mol) of ethyl 2-cyano-3,3-diphenylacrylate (Uvinul 3035), 200 ml of cyclohexanol and 10 g of Na[0103] 2CO3 were reacted together at 150° C. with distillative removal of the ethanol formed, assisted by a stream of nitrogen. After about 6 h, the reaction mixture was filtered hot in order to remove the Na2CO3. After the filtrate had been cooled, the precipitate which had formed was filtered off, washed with petroleum ether and dried, giving 111 g (67%) of cyclohexyl 2-cyano-3,3-diphenylacrylate as a colorless solid. [λmax 300 nm; E1 1, (MeOH) 381]
    • EXAMPLE 3 4-tert-butylcyclohexyl 2-cyano-3,3-diphenylacrylate
  • 139 g (0.5 mol) of ethyl 2-cyano-3,3-diphenylacrylate (Uvinul 3035), 200 ml of 4-tert-butylcyclohexanol and 10 g of Na[0104] 2CO3 were reacted together at 182° C. with distillative removal of the ethanol formed, assisted by a stream of nitrogen. After about 4 h, the reaction mixture was diluted with 300 ml of methanol and filtered hot in order to remove the Na2CO3. After the filtrate had been cooled, the precipitate which had formed was filtered off, washed with petroleum ether and dried, giving 130 g (67%) of 4-tert-butyl-cyclohexyl 2-cyano-3,3-diphenylacrylate as a colorless solid. [λmax 302 nm; E1 1 (MeOH) 324]
    • EXAMPLE 4 Norbornyl 2-cyano-3,3-diphenylacrylate
  • 55.4 g (0.2 mol) of ethyl 2-cyano-3,3-diphenylacrylate (Uvinul 3035), 100 g of norborneol and 4 g of Na[0105] 2CO3 were reacted with one another at about 185° C. with distillative removal of the ethanol formed, assisted by a stream of nitrogen. After about 4 h, the reaction mixture was filtered hot in order to remove the Na2CO3. After the filtrate had been cooled, the precipitate which had formed was filtered off, washed with cyclohexane and dried, giving 37 g (53%) of norbornyl 2-cyano-3,3-diphenylacrylate [λmax=304 nm, E1 1 =386] as a colorless solid.
    • EXAMPLE 5 2,2,6-Trimethylcyclohexyl 2-cyano-3,3-diphenylacrylate
  • 55.4 g (0.2 mol) of ethyl 2-cyano-3,3-diphenylacrylate (Uvinul 3035), 100 ml of 2,2,6-trimethylcyclohexanol and 4 g of Na[0106] 2CO3 were reacted with one another at 184-186° C. with distillative removal of the ethanol formed, assisted by a stream of nitrogen. After about 3 h, the reaction mixture was filtered hot in order to remove the Na2CO3. After the filtrate had been cooled, it was distilled under reduced pressure, giving 55 g (74%) of 2,2,6-trimethylcyclohexyl 2-cyano-3,3-diphenylacrylate [λmax=304 nm, E1 1=351] as a colorless solid.
    • EXAMPLE 6 3,3,5-Trimethylcyclohexyl 2-cyano-3,3-diphenylacrylate
  • 55.4 g (0.2 mol) of ethyl 2-cyano-3,3-diphenylacrylate (Uvinul 3035), 100 ml of 3,3,5-trimethylcyclohexanol and 4 g of Na[0107] 2CO3 were reacted with one another at 181-184° C. with distillative removal of the ethanol formed, assisted by a stream of nitrogen. After about 5 h, the reaction mixture was filtered hot in order to remove the Na2CO3. After the filtrate had been cooled, the precipitate which had formed was filtered off, washed with cyclohexane and dried, giving 29 g (39%) of 3,3,5-trimethylcyclohexyl 2-cyano-3,3-diphenylacrylate [λmax=301 nm, E1 1=344] as a colorless solid.
    • EXAMPLE 7 Menthyl 2-cyano-3,3-diphenylacrylate
  • 55.4 g (0.2 mol) of ethyl 2-cyano-3,3-diphenylacrylate (Uvinul 3035), 62.5 g of menthol and 4 g of Na[0108] 2CO3 were reacted with one another at 185-200° C. with distillative removal of the ethanol formed, assisted by a stream of nitrogen. After about 6 h, the reaction mixture was cooled and distilled under reduced pressure, giving 44 g (57%) of menthyl 2-cyano-3,3-diphenylacrylate [λmax=300 nm, E1 1=351].
    • II. PREPPARATIONS EXAMPLE 8
  • Composition for lip care [0109]
    Mass content
    (% by weight)
    ad 100 Eucerinum anhydricum
    10.00 glycerol
    10.00 titanium dioxide, micronized
    3.00 cyclohexyl 2-cyano-3,3-diphenylacrylate
    (prepared as in Example 2)
    1.50 4-tert-butyl-4′-methoxydibenzoylmethane
    8.00 octyl methoxycinnamate
    5.00 zinc oxide
    4.00 castor oil
    4.00 pentaerythritil stearate/caprate/caprylate/adipate
    3.00 glyceryl stearate SE
    2.00 beeswax
    2.00 microcrystalline wax
    2.00 quaternium-18 bentonite
    1.50 PEG-45/dodecyl glycol copolymer
    • EXAMPLE 9
  • Composition for sun blocker containing micropigments [0110]
    Mass content
    (% by weight)
    ad 100 water
    10.00 octyl methoxycinnamate
    6.00 PEG-7 hydrogenated castor oil
    6.00 titanium dioxide, micronized
    3.00 cyclohexyl 2-cyano-3,3-diphenylacrylate
    (prepared as in Example 2)
    1.50 4-tert-butyl-4′-methoxydibenzoylmethane
    5.00 mineral oil
    5.00 isoamyl p-methoxycinnamate
    5.00 propylene glycol
    3.00 jojoba oil
    3.00 4-methylbenzylidenecamphor
    2.00 PEG-45/dodecyl glycol copolymer
    1.00 dimethicone
    0.50 PEG-40 hydrogenated castor oil
    0.50 tocopheryl acetate
    0.50 phenoxyethanol
    0.20 EDTA
    • EXAMPLE 10
  • Non-greasy gel [0111]
    Mass content
    (% by weight)
    ad 100 water
    8.00 octyl methoxycinnamate
    7.00 titanium dioxide, micronized
    3.00 cyclohexyl 2-cyano-3,3-diphenylacrylate
    (prepared as in Example 2)
    1.50 4-tert-butyl-4′-methoxydibenzoylmethane
    5.00 glycerol
    5.00 PEG-25 PABA
    1.00 4-methylbenzylidenecamphor
    0.40 acrylates C10-C30 alkyl acrylate crosspolymer
    0.30 imidazolidinylurea
    0.25 hydroxyethylcellulose
    0.25 sodium methylparaben
    0.20 disodium EDTA
    0.15 fragrance
    0.15 sodium propylparaben
    0.10 sodium hydroxide
    • EXAMPLE 11
  • Suncream (SPF 20) [0112]
    Mass content
    (% by weight)
    ad 100 water
    8.00 octyl methoxycinnamate
    8.00 titanium dioxide, micronized
    6.00 PEG-7 hydrogenated castor oil
    3.00 cyclohexyl 2-cyano-3,3-diphenylacrylate
    (prepared as in Example 2)
    1.50 4-tert-butyl-4′-methoxydibenzoylmethane
    6.00 mineral oil
    5.00 zinc oxide
    5.00 isopropyl palmitate
    0.30 imidazolidinylurea
    3.00 jojoba oil
    2.00 PEG-45/dodecyl glycol copolymer
    1.00 4-methylbenzylidenecamphor
    0.60 magnesium stearate
    0.50 tocopheryl acetate
    0.25 methylparaben
    0.20 disodium EDTA
    0.15 propylparaben
    • EXAMPLE 12
  • Water-resistant suncream [0113]
    Mass content
    (% by weight)
    ad 100 water
    8.00 octyl methoxycinnamate
    5.00 PEG-7 hydrogenated castor oil
    5.00 propylene glycol
    4.00 isopropyl palmitate
    4.00 caprylic/capric triglyceride
    3.00 cyclohexyl 2-cyano-3,3-diphenylacrylate
    (prepared as in Example 2)
    1.50 4-tert-butyl-4′-methoxydibenzoylmethane
    4.00 glycerol
    3.00 jojoba oil
    2.00 4-methylbenzylidenecamphor
    2.00 titanium dioxide, micronized
    1.50 PEG-45/dodecyl glycol copolymer
    1.50 dimethicone
    0.70 magnesium sulfate
    0.50 magnesium stearate
    0.15 fragrance
    • EXAMPLE 13
  • Sunmilk (SPF 6) [0114]
    Mass content
    (% by weight)
    ad 100 water
    10.00 mineral oil
    6.00 PEG-7 hydrogenated castor oil
    5.00 isopropyl palmitate
    3.50 octyl methoxycinnamate
    3.00 cyclohexyl 2-cyano-3,3-diphenylacrylate
    (prepared as in Example 2)
    1.50 4-tert-butyl-4′-methoxydibenzoylmethane
    3.00 caprylic/capric triglyceride
    3.00 jojoba oil
    2.00 PEG-45/dodecyl glycol copolymer
    0.70 magnesium sulfate
    0.60 magnesium stearate
    0.50 tocopheryl acetate
    3.00 glycerol
    0.25 methylparaben
    0.15 propylparaben
    0.05 tocopherol
    • EXAMPLE 14
  • Day lotion with UV protection [0115]
    Mass content
    (% by weight)
    ad 100 water
    2.00 cetearyl alcohol
    1.00 glycerol monostearate
    2.00 vaseline
    7.50 octyl methoxycinnamate
    4.00 octyl salicylate
    3.00 cyclohexyl 2-cyano-3,3-diphenylacrylate
    (prepared as in Example 2)
    1.50 4-tert-butyl-4′-methoxydibenzoylmethane
    0.50 dimethicone
    5.00 propylene glycol
    0.20 EDTA
    0.20 carbomer
    5.00 C12-C15-alkyl benzoate
    0.27 triethanolamine
    1.00 tocopheryl acetate
    q.s. fragrance
    • EXAMPLE 15
  • Daycream with UV protection [0116]
    Mass content
    (% by weight)
    ad 100 water
    2.00 cetearyl alcohol
    2.00 cetyl alcohol
    1.00 glycerol monostearate
    2.00 vaseline
    7.50 octyl methoxycinnamate
    4.00 octyl salicylate
    3.00 cyclohexyl 2-cyano-3,3-diphenylacrylate
    (prepared as in Example 2)
    1.50 4-tert-butyl-4′-methoxydibenzoylmethane
    4.00 propylene glycol
    0.20 EDTA
    0.20 carbomer
    0.20 xanthan
    0.20 C10-C30-alkyl acrylate crosspolymer
    5.00 C12-C15-alkyl benzoate
    0.54 triethanolamine
    1.00 tocopheryl acetate
    q.s. fragrance
    q.s. preservative
    • EXAMPLE 16
  • Liquid make-up [0117]
    Mass content
    (% by weight)
    ad 100 water
    2.00 cetearyl alcohol
    2.00 ceteareth 25
    6.00 glycerol monostearate
    1.00 cetyl alcohol
    8.00 paraffin oil
    7.00 cetearyl octanoate
    0.2 dimethicone
    3.00 propylene glycol
    1.00 panthenol
    3.00 cyclohexyl 2-cyano-3,3-diphenylacrylate
    (prepared as in Example 2)
    1.50 4-tert-butyl-4′-methoxydibenzoylmethane
    3.50 octyl methoxycinnamate
    0.1 bisabolol
    5.70 titanium dioxide
    1.10 iron oxide
    q.s. fragrance
    • EXAMPLE 17
  • Hair gel with sun protection [0118]
    Mass content
    (% by weight)
    ad 100 water
    1.20 carbomer
    0.50 hydroxyethylcellulose
    4.00 triethanolamine
    0.70 PEG-40 hydrogenated castor oil
    1.50 cyclohexyl 2-cyano-3,3-diphenylacrylate
    (prepared as in Example 2)
    0.70 4-tert-butyl-4′-methoxydibenzoylmethane
    2.80 octyl methoxycinnamate
    5.00 propylene glycol
    0.01 EDTA
    q.s. fragrance
    q.s. Sicovit Patent Blue 85 E 131
    • EXAMPLE 18
  • Standardized method for determining photostability (sun test) [0119]
  • A 2% strength by weight alcoholic solution of the light protection agent to be tested was applied, using an Eppendorf pipette (20 μl), to the milled area of a small glass plate. Owing to the presence of the alcohol, the solution distributed uniformly on the roughened surface of the glass. (The amount applied corresponds to the amount of light protection agent required to achieve an average sun protection factor in suncreams.) In the test, 4 small glass plates were irradiated in each case. The irradiation time was 30/60/90/120 minutes in each case. The small glass plates were cooled slightly during irradiation by water cooling located at the base of the suntest apparatus. The temperature inside the sun test apparatus was 40° C. during irradiation. After the samples had been irradiated, they were washed with ethanol in a dark 50 ml graduated flask, and measured using a photometer. The blank samples were likewise applied to small glass plates and evaporated for 30 minutes at room temperature. Like the other samples, they were washed off with ethanol, diluted to 100 ml and measured. [0120]
    Photostability Photostability Photostability
    of Parsol of Parsol 1789 of Parsol 1789
    1798*) without containing 1% containing 2%
    Stabilizer stabilizer of stabilizer of stabilizer
    Compound from 30 min**): 64% 30 min: 92% 30 min: 94%
    Example 1 60 min: 28% 60 min: 81% 60 min: 90%
    90 min: 12% 90 min: 69% 90 min: 85%
    Compound from 30 min: 64% 30 min: 95% 30 min: 94%
    Example 2 60 min: 28% 60 min: 81% 60 min: 89%
    90 min: 12% 90 min: 73% 90 min: 85%
    Compound from 30 min: 64% 30 min: 87% 30 min: 96%
    Example 3 60 min: 28% 60 min: 80% 60 min: 85%
    90 min: 12% 90 min: 65% 90 min: 81%
  • *) 4-(1,1-Dimethylethyl)-4′-methoxydibenzoylmethane [0121]
  • **) Irradiation time [0122]

Claims (11)

We claim:
1. A cosmetic or dermatological preparation comprising
a) 0.1 to 10% by weight of one or more 3,3-diphenylacrylates of the formula I,
Figure US20010028888A1-20011011-C00009
 in which the substituents independently of one another have the following meanings:
R1 and R2 are hydrogen, C1-C12-alkyl, C1-C12-alkoxy;
R3 is C3-C10-cycloalkyl, optionally substituted;
R4 is hydrogen, CN and
b) 0.1 to 10% by weight of one or more dibenzoylmethane derivatives of the formula II,
Figure US20010028888A1-20011011-C00010
 in which the substituents independently of one another have the following meanings:
R5 to R8 are hydrogen, C1-C4-alkyl;
R9 and R10 are hydrogen, C1-C12-alkyl, C1-C12-alkoxy.
2. A cosmetic or dermatological preparation as claimed in
claim 1
, comprising
a) 0.1 to 10% by weight of one or more 3,3-diphenylacrylates of the formula Ib,
Figure US20010028888A1-20011011-C00011
 in which R3 is C5-C8-cycloalkyl, optionally substituted, and
b) 0.1 to 10% by weight of one or more dibenzoylmethane derivatives, chosen from the group consisting of
2-methyldibenzoylmethane, 4-methyldibenzoylmethane,
4-isopropyldibenzoylmethane,
4-tert-butyldibenzoylmethane,
2,4-dimethyldibenzoylmethane,
2,5-dimethyldibenzoylmethane,
4,4′-diisopropyldibenzoylmethane,
4-tert-butyl-4′-methoxydibenzoylmethane,
2-methyl-5-isopropyl-4′-methoxydibenzoylmethane,
2-methyl-5-tert-butyl-4′-methoxydibenzoylmethane,
2,4-dimethyl-4′-methoxydibenzoylmethane,
2,6-dimethyl-4-tert-butyl-4′-methoxydibenzoylmethane.
3. A cosmetic or dermatological preparation as claimed in either of claims 1 or 2, comprising
a) 0.1 to 10% by weight of one or more 3,3-diphenylacrylates of the formula Ib,
Figure US20010028888A1-20011011-C00012
 in which R3 is C5-C8-cycloalkyl, optionally substituted, and
b) 0.1 to 10% by weight of 4-tert-butyl-4′-methoxydibenzoylmethane.
4. A cosmetic or dermatological preparation as claimed in any of
claims 1
 to
3
, comprising 0.1 to 6% by weight of component a).
5. A cosmetic or dermatological preparation as claimed in any of
claims 1
 to
4
, comprising 1.5 to 2.5% by weight of component a).
6. A cosmetic or dermatological preparation as claimed in any of
claims 1
 to
5
, comprising 0.2 to 7% by weight of component b).
7. A cosmetic or dermatological preparation as claimed in any of
claims 1
 to
6
, comprising 0.4 to 5% by weight of component b).
8. A cosmetic or dermatological preparation as claimed in any of
claims 1
 to
7
, comprising components a) and b) in a molar ratio a:b of 0.5 to 10.
9. A cosmetic or dermatological preparation as claimed in any of
claims 1
 to
8
, comprising components a) and b) in a molar ratio a:b of 1 to 8.
10. A cosmetic or dermatological preparation as claimed in any of
claims 1
 to
9
 having a sun protection factor of >10.
11. The use of cosmetic or dermatological preparations, defined as in
claim 1
, for the protection of the human skin or human hair against solar rays, alone or together with compounds which absorb in the UV region and are known per se for cosmetic or dermatological preparations.
US09/771,593 2000-02-29 2001-01-30 Cosmetic or dermatological light protection agent preparations Expired - Fee Related US6416773B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE10009442A DE10009442A1 (en) 2000-02-29 2000-02-29 Cosmetic or dermatological compositions comprising a dibenzoylmethane derivative, useful as sunscreens, include a cycloalkyl 3,3-diphenylacrylate photostabilizer
DE10009442 2000-02-29
DE10044351 2000-09-07
DE2000144351 DE10044351A1 (en) 2000-09-07 2000-09-07 Cosmetic or dermatological compositions comprising a dibenzoylmethane derivative, useful as sunscreens, include a cycloalkyl 3,3-diphenylacrylate photostabilizer
DE10009442.2 2000-09-07

Publications (2)

Publication Number Publication Date
US20010028888A1 true US20010028888A1 (en) 2001-10-11
US6416773B2 US6416773B2 (en) 2002-07-09

Family

ID=26004566

Family Applications (1)

Application Number Title Priority Date Filing Date
US09/771,593 Expired - Fee Related US6416773B2 (en) 2000-02-29 2001-01-30 Cosmetic or dermatological light protection agent preparations

Country Status (5)

Country Link
US (1) US6416773B2 (en)
EP (1) EP1129695A1 (en)
JP (1) JP2001240525A (en)
CN (1) CN1310994A (en)
BR (1) BR0100691A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010129318A2 (en) * 2009-05-04 2010-11-11 Elc Management Llc Topical compositions comprising an alkoxylated diphenylacrylate compound and an organic nonionic emulsifier
WO2010129445A3 (en) * 2009-05-04 2011-02-03 Elc Management Llc Topical compositions comprising inorganic particulates and an alkoxylated diphenylacrylate compound
US9095543B2 (en) 2009-05-04 2015-08-04 Elc Management Llc Cosmetic compositions comprising cyanodiphenylacrylates
US11357713B2 (en) 2015-07-14 2022-06-14 Conopco, Inc. Antimicrobial composition

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7041278B2 (en) * 2002-07-31 2006-05-09 Coty Inc Cosmetic compositions with improved thermal stability and wear
US6919473B2 (en) * 2002-09-17 2005-07-19 Cph Innovations Corporation Photostabilizers, UV absorbers, and methods of photostabilizing a sunscreen composition
US7799317B2 (en) * 2002-11-22 2010-09-21 Hallstar Innovations Corp. Photostabilizers, UV absorbers, and methods of photostabilizing compositions
US7544350B2 (en) * 2002-11-22 2009-06-09 Hallstar Innovations Corp. Method of decreasing the UV light degradation of polymers
AU2003240693A1 (en) * 2003-05-22 2004-12-13 Kemira Pigments Oy Inorganic light-absorbing micropigments and the use thereof
CA2526626C (en) * 2003-05-29 2012-08-28 Sun Pharmaceuticals Corporation Emulsion base for skin care compositions
US7276230B2 (en) * 2003-12-23 2007-10-02 Avon Products, Inc. Sunscreen compounds and compositions containing same and methods for use thereof
US7534420B2 (en) * 2004-02-25 2009-05-19 Hallstar Innovations Corp. Compounds derived from polyanhydride resins with film-forming, UV-absorbing, and photostablizing properties, compositions containing same, and methods of using the same
US7235587B2 (en) * 2004-07-01 2007-06-26 Cph Innovations Corporation Diesters containing two crylene or fluorene moieties, sunscreen compositions containing the same, and methods of photostabilizing a sunscreen compositions containing the same
US7767233B2 (en) * 2004-08-06 2010-08-03 Himalaya Global Holdings, Ltd. Natural hair care composition, methods for obtaining the same and use thereof
WO2006034968A1 (en) * 2004-09-29 2006-04-06 Ciba Specialty Chemicals Holding Inc. Photo-stable cosmetic or dermatological compositions
US8158678B2 (en) * 2005-04-07 2012-04-17 Cph Innovations Corp. Photoabsorbing, highly conjugated compounds of cyanoacrylic esters, sunscreen compositions and methods of use
US8133477B2 (en) * 2007-08-09 2012-03-13 Hallstar Innovations Corp. Dispersions of inorganic particulates containing alkoxycrylene
WO2009077356A2 (en) * 2007-12-14 2009-06-25 Basf Se Sunscreen compositions comprising colour pigmens

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB976968A (en) * 1961-03-09 1964-12-02 Gen Aniline & Film Corp Organic compositions stabilized with ª‡-cyano-ª‰,ª‰-diphenyl acrylic acid compounds
US3275520A (en) * 1962-05-29 1966-09-27 Gen Aniline & Film Corp Methods for protecting the skin against actinic radiations
NL190101C (en) 1978-11-13 1993-11-01 Givaudan & Cie Sa DIBENZOYL METHANE COMPOUND AND ANTI-LIGHT PROTECTIVE PREPARATION.
SU1051075A1 (en) * 1982-07-05 1983-10-30 Научно-исследовательский институт химикатов для полимерных материалов Process for preparing 2,2,6,6-tetramethyl-4-piperidyl-beta,beta-prim-diphenyl-alpha-cyaneacrylate
DE3314742C2 (en) 1983-04-23 1987-04-02 Degussa Ag, 6000 Frankfurt Process for the preparation of surface-modified natural, oxidic or silicate fillers and their use
US5587150A (en) * 1990-02-14 1996-12-24 L'oreal Photostable cosmetic screening composition containing a UV-A screening agent and an alkyl β, β-diphenylacrylate or α-cyano-β,β-diphenylacrylate
FR2658075B1 (en) 1990-02-14 1992-05-07 Oreal PHOTOSTABLE FILTERING COSMETIC COMPOSITION CONTAINING A UV-A FILTER AND A BETA, BETA-DIPHENYLACRYLATE OR ALPHA-CYANO-BETA, BETA-DIPHENYLACRYLATE.
US5280380A (en) * 1990-04-30 1994-01-18 Gentex Corporation UV-stabilized compositions and methods
JP3560243B2 (en) * 1992-02-03 2004-09-02 ヘキスト・セラニーズ・コーポレーション 4'-hydroxyacetophenone, 4-hydroxystyrene, 1,1,1-tris (4'-hydroxyphenyl) ethane, and 1,3,5-tris (4 ') which are ultraviolet stabilizers, antioxidants and colorants -Hydroxyphenyl) benzene derivatives
US5510228A (en) * 1995-02-17 1996-04-23 Eastman Kodak Company 2-cyano-3,3-diarylacrylate UV dyes for laser recording process
US6033649A (en) * 1995-12-18 2000-03-07 Roche Vitamins Inc. Light screening agents
US5989528A (en) * 1998-07-30 1999-11-23 The Procter & Gamble Company Sunscreen compositions

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010129318A2 (en) * 2009-05-04 2010-11-11 Elc Management Llc Topical compositions comprising an alkoxylated diphenylacrylate compound and an organic nonionic emulsifier
WO2010129445A3 (en) * 2009-05-04 2011-02-03 Elc Management Llc Topical compositions comprising inorganic particulates and an alkoxylated diphenylacrylate compound
WO2010129318A3 (en) * 2009-05-04 2011-02-24 Elc Management Llc Topical compositions comprising an alkoxylated diphenylacrylate compound and an organic nonionic emulsifier
US20110110988A1 (en) * 2009-05-04 2011-05-12 Milanka Susak Topical Compositions Comprising Inorganic Particulates And An Alkoxylated Diphenylacrylate Compound
US8765156B2 (en) 2009-05-04 2014-07-01 Elc Management Llc Topical compositions comprising inorganic particulates and an alkoxylated diphenylacrylate compound
US9095543B2 (en) 2009-05-04 2015-08-04 Elc Management Llc Cosmetic compositions comprising cyanodiphenylacrylates
US11357713B2 (en) 2015-07-14 2022-06-14 Conopco, Inc. Antimicrobial composition

Also Published As

Publication number Publication date
US6416773B2 (en) 2002-07-09
EP1129695A1 (en) 2001-09-05
BR0100691A (en) 2001-10-09
CN1310994A (en) 2001-09-05
JP2001240525A (en) 2001-09-04

Similar Documents

Publication Publication Date Title
US6387355B2 (en) Use of sunscreen combinations comprising, as essential constituent, amino-substituted hydroxybenzophenones as photostable UV filters in cosmetic and pharmaceutical preparations
US6391289B2 (en) Use of sunscreen combinations comprising, as essential constituent, 4,4′-diarylbutadienes as photostable UV filters in cosmetic and pharmaceutical preparations
US6409995B1 (en) Use of amino-substituted hydroxybenzophenones as photostable UV filters in cosmetic and pharmaceutical preparations
US6416773B2 (en) Cosmetic or dermatological light protection agent preparations
US7208142B2 (en) Indanylidene compounds
US20080050319A1 (en) Benzylidene-Alpha-Dicarbonyl Compounds as Novel Uv Absorbers
US20020016310A1 (en) Cosmetic and pharmaceutical preparations containing photostable UV filters
US6488915B1 (en) Use of sunscreen combinations which comprise, as essential constituent, 2-(4-alkoxyanilinomethylene) malonic dialkyl esters as photostable UV filters in cosmetic and pharmaceutical preparations
US6458342B1 (en) Use of sunscreen combinations comprising, as essential constituent, 2,2′-p-phenylenebis (3,1-benzoxazin-4-one) as photostable UV filters in cosmetic and pharmaceutical preparations
US20050249681A1 (en) Use of diketopiperazine derivatives as photostable uv-filters in cosmetic and pharmaceutical preparations
US5968484A (en) Cosmetic preparations comprising photostable UV-A filters
US6090374A (en) Cosmetic and pharmaceutical preparations comprising photostable UV filters
US20070028401A1 (en) Powdered preparations containing a mixture of 2,4,6-trianilino-p-(carbo-2'-ethylhexyl-1'-oxi)-1,3,5-triazine and diethylamino-hydroxybenzoyl-hexyl-benzoate
AU2476401A (en) Cosmetic or dermatological light protection agent preparations
CA2234121C (en) Cosmetic formulations containing photostable uv-a filters
AU750506B2 (en) Cosmetic and pharmaceutical preparations containing photostable UV filters
US20060246018A1 (en) Mixture consisting of uv-a and uv-b filters
DE10044351A1 (en) Cosmetic or dermatological compositions comprising a dibenzoylmethane derivative, useful as sunscreens, include a cycloalkyl 3,3-diphenylacrylate photostabilizer

Legal Events

Date Code Title Description
AS Assignment

Owner name: BASF AKTIENGESELLSCHAFT, GERMANY

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:HEIDENFELDER, THOMAS;SCHEHLMANN, VOLKER;WUENSCH, THOMAS;AND OTHERS;REEL/FRAME:011489/0250;SIGNING DATES FROM 20001123 TO 20001205

REMI Maintenance fee reminder mailed
LAPS Lapse for failure to pay maintenance fees
STCH Information on status: patent discontinuation

Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362

FP Lapsed due to failure to pay maintenance fee

Effective date: 20060709